Developing Fast Pediatric Imaging
ConditionPediatric Low-grade Gliomas
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age0+
SponsorBoston Children's Hospital
About this trial
This research study is evaluating the investigational software for magnetic resonance imaging (MRI) systems and techniques to process magnetic resonance (MR) images
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Infants, children and adults who have been diagnosed with Low Grade Glioma
Healthy volunteers - Children from age 0 to adults with no upper age limit or;
Diagnosed with LGG and being treated at DFCI;
Disqualifiers
Electrical implants such as cardiac pacemakers or perfusion pumps;
Ferromagnetic implants such as aneurysm clips, surgical clips, prosthesis, artificial hearts, valves with steel parts, metal fragments, shrapnel, tattoos near the eye, or steel implants;
Ferromagnetic objects such as jewelry or metal clips;
Women of childbearing age who are seeking to become pregnant, who are breastfeeding, or who suspect they may be pregnant;
Trial design
Design model
Parallel
Treatments tested in this trial
Wave-CAIPI
Other intervention"wave-CAIPI" technology, a data acquisition / reconstruction scheme designed to optimally exploit available information in modern multi-channel receivers and in multi-contrast/time-series data for improved image encoding
Treatment groups
300 Participants
are divided into 2 treatment groupsGroup A: Primary Testing GroupExperimental treatment 1 intervention
Group B: Software Testing GroupExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Wave-CAIPI validation
The outcome measure for this project will be that the rapid scan from Wave-CAIPI can provide equivalent diagnostic quality to that of standard clinical acquisitions which is performed at much slower speed. This will be assess using visual qualitative assessment by experienced radiologists on the project.
Time frame
2 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Boston Children's Hospital
Lead sponsor
National Institute for Biomedical Imaging and Bioengineering (NIBIB)
Collaborator
Dana-Farber Cancer Institute
Collaborator
Source ClinicalTrials.gov